Application for Maryland Biotechnology Center
Translational Research Awards
Purpose: Maryland is globally recognized as one of the largest clusters of research intensity in the life
sciences across its academic, federal and industry sectors. The Maryland Biotechnology Center seeks to
catalyze the “translation” of this early stage bioscience research into commercially viable products or
services. Identification of research that lends itself to commercial applicability and providing critical
“proof of concept” funding is critical to this effort. Also critical is leveraging discoveries across sectors
and disciplines in a collaborative environment. This award program favors projects that involve
interactions between the State’s academic research programs and those in private companies that
provide a clear path to move promising research on a viable commercialization path.
The Award: The award minimum may not exceed $200,000 per awardee per annual award cycle. Funds
will be released in project phases tied to successful completion of identified milestones. Companies
must apply 100% of project costs financed by the award to direct costs for tasks associated with the
milestones. The project should be able to achieve all indicated milestones within one year. The award is
a repayable grant. Repayment obligation initiates following completion of the funded project, at 3% of
company revenue (excluding grants and awards) capped at 40% of the award per year not to exceed 2x
the award amount. University-only awards are repaid at a rate of 25% of royalty revenue not to exceed
2x the award amount.
Who can apply: Applications may be submitted by principal investigators from either private bioscience
companies or from research universities located in Maryland. Formal collaborative (joint) submissions
that advance research discoveries toward development of a product are encouraged and will receive
priority. University sponsored projects must receive prior authorization to apply and have undergone
due diligence from their technology transfer office.
Application: The applicant will identify the project and specific milestones to be completed with the
funding, including a budget that is linked to these milestones.
The applicant must:
1. Complete the Applicant and Project Summary Forms
2. Complete the Application Details Form and include a Principal Investigator CV.
3. Companies must provide a full business plan including a 5 year pro forma financial statement,
and any current and submitted grant applications including title, abstract, duration dates and
budget total. University applicants must provide a list of all related current and submitted grant
applications, including title, abstract, duration dates and budget total.
4. Submit electronically to grants@marylandbiocenter.org
5. Be prepared to present the project to a review panel at the Maryland Biotechnology Center
Maryland Biotechnology Center
Page 1 / 7
Translational Research Application
TRANSLATIONAL RESEARCH
APPLICATION DETAIL
Project Title
Project Contact
Area of Translational
Research
(check any that apply)
__ Therapeutics
__ Diagnostics __ Medical Devices
__ Nanobiotechnology __ AgBio
__ Research Tools
__Industrial Bio __Other:
DESCRIPTION OF
PROJECT GOALS
State (1) the project goal(s)
and describe how the
project goal(s) fits into the
product development plan
or service, and (2) benefits
the organization by
addressing an unmet
need(s).
1000 word limit
(Arial 10 or Calibri 11 font)
CONFIDENTIAL
Maryland Biotechnology Center
Page 2 / 7
Translational Research Application
PROJECT MILESTONES
Identify the project
milestone(s) and relate
each to the project goal(s).
1000 word limit
(Arial 10 or Calibri 11 font)
CONFIDENTIAL
STAGE OF
DEVELOPMENT
Identify the current stage
of development of this
project in terms of (1) prior
work, staffing and
investment to date, and (2)
after the successful
completion of these
milestones, what the
expected next steps in the
development path (e.g.
patent, clinical trial,
regulatory activity) are to
commercialization.
1000 word limit
(Arial 10 or Calibri 11 font)
CONFIDENTIAL
Maryland Biotechnology Center
Page 3 / 7
Translational Research Application
EXPECTED OUTCOMES
AND FUTURE
COMMERCIALIZATION
OBJECTIVES
Describe the expected
outcomes of each
milestone and for the
project as a whole.
Indicate future
commercialization plan for
this project including
timeline and estimated
required funding.
1000 word limit
(Arial 10 or Calibri 11 font)
CONFIDENTIAL
Maryland Biotechnology Center
Page 4 / 7
Translational Research Application
INTELLECTUAL
PROPERTY/PATENT
LANDSCAPE
Describe the Intellectual
Property (IP) or proprietary
knowledge protection
prospects of the intended
commercialization
endpoint. Note any
complementary or blocking
patents or technology that
would need to be licensed
to successfully
commercialize this product
(freedom to operate).
1000 word limit
(Arial 10 or Calibri 11 font)
CONFIDENTIAL
Maryland Biotechnology Center
Page 5 / 7
Translational Research Application
DETAILED BUDGET
Provide a detailed project
budget. Indicate total
project expenses,
leveraged or additional
funding in place or
anticipated (by when),
their sources, and
dedicated project staff and
their annual labor costs.
For Universities: Overhead
costs are not funded by
this award.
Expenses must be tied to
project milestones stated
above.
1000 word limit
(Arial 10 or Calibri 11 font
This information may be
submitted on an Excel
spreadsheet
CONFIDENTIAL
Maryland Biotechnology Center
Page 6 / 7
Translational Research Application
UNIVERSITY APPLICANTS ONLY – COMPLETE THE ADDITIONAL SECTION BELOW
MARKET ANALYSIS
Provide (1) an analysis of
the target market and
market size, and (2) an
analysis of competitor
companies or
organizations with similar
products or services in
development or on the
market.
1000 word limit
(Arial 10 or Calibri 11 font
CONFIDENTIAL
Maryland Biotechnology Center
Page 7 / 7
Translational Research Application